Compounds > n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine
Page last updated: 2024-08-26

n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine and Substance Withdrawal Syndrome

n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine has been researched along with Substance Withdrawal Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kotlińska, J; Langwiński, R1

Other Studies

1 other study(ies) available for n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine and Substance Withdrawal Syndrome

ArticleYear
Audiogenic seizures during ethanol withdrawal can be blocked by a delta opioid agonist.
    Drug and alcohol dependence, 1986, Volume: 18, Issue:4

    Topics: Acoustic Stimulation; Animals; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalin, Methionine; Ethanol; Female; Naloxone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Seizures; Substance Withdrawal Syndrome

1986